-
Professor Ren Changliang and his collaborators have made important progress in the construction
Time of Update: 2022-11-04
Recently, the team of Professor Ren Changliang, School of Pharmacy, State Key Laboratory of Cell Stress Biology, Fujian Provincial Key Laboratory of New Drug Target Research, and the team of Professo
-
Dr. Cai Yi walks with "swollen": looking back on the past and making his own voice in the field of prostate cancer
Time of Update: 2022-02-23
Insufficient existing treatment plans , insufficient patient benefits, and urgent desire of doctors to improve diagnosis and treatment methods are the driving forces that drive the continuous clinical research in the field of prostate cancer and the development and renewal of more drugs .
-
Dr. Cai Yi walks with "swollen": looking back on the past and making his own voice in the field of prostate cancer
Time of Update: 2022-01-26
Insufficient existing treatment plans , insufficient patient benefits, and urgent desire of doctors to improve diagnosis and treatment methods are the driving forces that drive the continuous clinical research in the field of prostate cancer and the development and renewal of more drugs .
-
The Stone of His Mountain Can Attack Jade: The "Three-Plate Axe" of China's Lung Cancer Survival Leap
Time of Update: 2021-02-24
Based on some of the current evidence and our research, we propose a treatment process based on the general principle that combined common mutations require joint targeted therapy or chemotherapy; EGFR inhibition is insufficient and requires increased dosage or penetration: What are the real dilemmas for early screening of lung cancer in China?
-
Luck or genius: from DMSO to the cancer drug Volino on his legendary path
Time of Update: 2021-01-03
researchers further screened the induced differentiation activity of more active derivatives on HL-60 and HT-29 cells, and the results showed that compound 16 had the best activity.
-
JAMA Oncol: Relationship between hearing impairment (HI) and neurocognitability in childhood cancer survivors.
Time of Update: 2020-09-02
recently, a cross-sectional study published by American scholars in jama Oncology further analyzed the relationship between hearing sensitivity and task-specific neurocognitive function in the queue of long-term survivors of childhood cancer by treating exposure layering.
-
Reality version Zhao Dehan! The director of a department at Tianjin Cancer Hospital has been suspended for hiding cigarettes in his refrigerator.
Time of Update: 2020-08-14
doctor received gifts from patients suspended in response to this matter, reporters from Tianjin Medical University Cancer Hospital official website learned that On May 13 at 2 p.m., Tianjin Medical University Cancer Hospital held an emergency meeting of the whole hospital, the jaw otolaryngology oncology department director Wang Xudong illegal acceptance of patient gifts treatment decision to inform.
-
The new treatment target for lung sarcoma-like cancer (PSC) - MET Exon 14 jump mutation, Volitinib can show his hand!
Time of Update: 2020-06-05
As we all know, pulmonary sarcoma-like cancer (PSC) is relatively low in non-small cell lung cancer, because of its unique clinical manifestations, in the pathological type of lung cancer can not b
-
Nobel Prize winner's story: He nearly gave up his research and discovered the key to cancer-suppressing genes
Time of Update: 2020-06-01
Professor William G Kaelin (left), Professor Peter J Ratcliffe (centre), and Professor Gregg L Semenza (right) (pictured) don't know how William felt when he heard about the award You know, a few dec
-
Mol Cancer Res: overcome the drug resistance of pancreatic cancer, and the combination of new drugs makes the king of cancer bow his head and admit defeat
Time of Update: 2019-08-23
August 23, 2019 / bioin / - pancreatic cancer is one of the most deadly cancers Once the disease spreads, the average survival of patients is less than one year, and there is an urgent need to evaluat
-
Professor Wang Qigang and his collaborators of Tongji University develop new materials to simulate neutrophil lysosomes for cancer treatment
Time of Update: 2019-02-17
As the first natural immune cell migrating to tumor tissue, neutrophils can kill abnormal cells immediately and activate long-term specific adaptive immune response Therefore, enzyme-mediated reactive
-
with the president of the American Cancer Research Foundation and his delegation
Time of Update: 2017-11-01
Source: on October 30, 2017-11-01, at the second China Pharmaceutical Innovation and Investment Conference (hereinafter referred to as "the conference"), song Ruilin, executive chairman of China Pharm
-
Novartis and his next cancer Adventure
Time of Update: 2014-07-08
Source: Swissinfo 2014-07-08 why Novartis is willing to pay GlaxoSmithKline 16 billion US dollars (about RMB 100 billion) in exchange for a series of cancer drugs that were not sold well before? Analy